These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

79 related items for PubMed ID: 7028255

  • 21. Immediate versus postponed combination chemotherapy (CAMP) for unresectable non-small cell lung cancer: a randomized trial.
    Lad TE, Nelson RB, Diekamp U, Kukla LJ, Sarma PR, Larson CS, Currie ET, Chawla MS, Tichler T, Zawila P, McGuire WP.
    Cancer Treat Rep; 1981; 65(11-12):973-8. PubMed ID: 7028259
    [Abstract] [Full Text] [Related]

  • 22. Adjuvant chemotherapy following radical surgery for non-small-cell lung cancer: a randomized study on 70 patients.
    Xu G, Rong T, Lin P.
    Chin Med J (Engl); 2000 Jul; 113(7):617-20. PubMed ID: 11776031
    [Abstract] [Full Text] [Related]

  • 23. Chemotherapy in advanced ovarian carcinoma: current standards of care based on randomized trials.
    Thigpen T, Vance R, Puneky L, Khansur T.
    Gynecol Oncol; 1994 Dec; 55(3 Pt 2):S97-107. PubMed ID: 7835816
    [Abstract] [Full Text] [Related]

  • 24. Phase II evaluation of the combination of triazinate, cyclophosphamide, doxorubicin, and cis-diamminedichloroplatinum(II) in patients with advanced adenocarcinoma of the lung.
    Eagan RT, Frytak S, Ingle JN, Creagan ET, Nichols WC, Kvols LK.
    Cancer Treat Rep; 1980 Dec; 64(8-9):925-8. PubMed ID: 7192602
    [Abstract] [Full Text] [Related]

  • 25. A phase II study of cisplatin and 5-fluorouracil with concurrent hyperfractionated thoracic radiation for locally advanced non-small-cell lung cancer: a preliminary report from the Okayama Lung Cancer Study Group.
    Segawa Y, Ueoka H, Kiura K, Kamei H, Tabata M, Sakae K, Hiraki Y, Kawahara S, Eguchi K, Hiraki S, Harada M.
    Br J Cancer; 2000 Jan; 82(1):104-11. PubMed ID: 10638975
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. A role of cis-dichlorodiammineplatinum(II) in squamous cell lung cancer.
    Eagan RT, Fleming TR, Frytak S, Creagan ET, Ingle JN, Kvols LK.
    Cancer Treat Rep; 1980 Jan; 64(1):87-91. PubMed ID: 6991107
    [Abstract] [Full Text] [Related]

  • 28. Evaluation of VP-16-213, cyclophosphamide, doxorubicin, and cisplatin (V-CAP) in advanced large cell lung cancer.
    Eagan RT, Frytak S, Nichols WC, Ingle JN, Creagan ET, Kvols LK, Coles DT.
    Cancer Treat Rep; 1981 Jan; 65(7-8):715-7. PubMed ID: 6166376
    [No Abstract] [Full Text] [Related]

  • 29. [Cis-dichlorodiammineplatinum, adriamycin and cyclophosphamide versus cis-dichlorodiammineplatinum, adriamycin, cyclophosphamide and CCNU in non-small cell carcinoma of the lung].
    Sanz Ortiz J, Saiz García F.
    Med Clin (Barc); 1981 Jan; 79(9):403-6. PubMed ID: 6296560
    [No Abstract] [Full Text] [Related]

  • 30. cis-Dichlorodiammineplatinum(II) in non-small cell carcinoma of the lung.
    Gralla RJ, Cvitkovic E, Golbey RB.
    Cancer Treat Rep; 1979 Jan; 63(9-10):1585-8. PubMed ID: 498158
    [Abstract] [Full Text] [Related]

  • 31. Chemotherapy for metastatic non-small cell bronchogenic carcinoma: EST 2575, generation III, HAM versus CAMP.
    Ruckdeschel JC, Mehta CR, Salazar OM, Creech RH, Sponzo RW.
    Cancer Treat Rep; 1981 Jan; 65(11-12):959-63. PubMed ID: 6794909
    [Abstract] [Full Text] [Related]

  • 32. Cyclophosphamide, adriamycin, and DTIC polychemotherapy in advanced small cell lung cancer.
    Saiontz HI, Dalton RJ, Eagan RT.
    Cancer Treat Rep; 1977 Jan; 61(3):481-3. PubMed ID: 194692
    [No Abstract] [Full Text] [Related]

  • 33. Future implications of phase 2 chemotherapy trials in ninety-five patients with measurable advanced bladder cancer.
    Yagoda A.
    Cancer Res; 1977 Aug; 37(8 Pt 2):2775-80. PubMed ID: 68814
    [No Abstract] [Full Text] [Related]

  • 34. Treatment of advanced adenocarcinoma of the lung with ftorafur, doxorubicin, cyclophosphamide, and cisplatin (FACP) and intensive iv hyperalimentation.
    Jordan WM, Valdivieso M, Frankmann C, Gillespie M, Issell BF, Bodey GP, Freireich EJ.
    Cancer Treat Rep; 1981 Aug; 65(3-4):197-205. PubMed ID: 6786737
    [No Abstract] [Full Text] [Related]

  • 35. Platinum-based polychemotherapy versus dianhydrogalactitol in advanced non-small cell lung cancer.
    Eagan RT, Ingle JN, Frytak S, Rubin J, Kvols LK, Carr DT, Coles DT, O'Fallon JR.
    Cancer Treat Rep; 1977 Oct; 61(7):1339-45. PubMed ID: 589599
    [No Abstract] [Full Text] [Related]

  • 36. [Results of combined treatment of advanced squamous cell carcinoma of the lung with vincristine, adriamycin and cyclophosphamide].
    Krawczyk K, Krochmal M, Pawlicki M, Kulpa J, Zielezińska A.
    Pneumonol Pol; 1983 Feb; 51(2):107-11. PubMed ID: 6878054
    [No Abstract] [Full Text] [Related]

  • 37. VP-16, cyclophosphamide, adriamycin and cis-platinum (V:CAP-I) in patients with metastatic adenocarcinoma of the lung.
    Eagan RT, Creagan ET, Ingle JN, Rubin J, Frytak S, Kvols LK, Fleming TR.
    Tumori; 1979 Feb 28; 65(1):105-9. PubMed ID: 442215
    [Abstract] [Full Text] [Related]

  • 38. Cyclophosphamide, adriamycin, and cis-diamminedichloroplatinum (II) in the treatment of patients with advanced head and neck cancer.
    Creagan ET, Fleming TR, Edmonson JH, Ingle JN, Woods JE.
    Cancer; 1981 Jan 15; 47(2):240-4. PubMed ID: 7193079
    [Abstract] [Full Text] [Related]

  • 39. Adriamycin and cyclophosphamide in the treatment of advanced carcinoma of the bladder.
    Choi TK, Lim ST, Wong KK, Ong GB.
    Clin Oncol; 1982 Jan 15; 8(3):237-42. PubMed ID: 6890420
    [No Abstract] [Full Text] [Related]

  • 40. Cisplatin combination chemotherapy in non-oat cell carcinoma of the lung.
    Vincent RG, Lane WW, Raza S, Madajewicz S.
    Cancer Treat Rep; 1982 Jan 15; 66(1):197-8. PubMed ID: 6975658
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 4.